VENOMAB IVS: Financial statements 2015
CVR: 35632271
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
VENOMAB IVS (CVR 35632271) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -6,815 and a net result of DKK -6,817 compared with DKK 0 the year before. Equity in the 2015 report amounted to DKK 7,069. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK -6,815
- Profit/Loss
- DKK -6,817
- Equity
- DKK 7,069
- Total Assets
- DKK 7,069
Official annual report
How creditworthy is VENOMAB IVS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
VENOMAB IVS has published its annual report for 2014. Revenue came to DKK 0, and the net result was DKK 0.
About VENOMAB IVS
VENOMAB IVS was a Danish company of the type Iværksætterselskab based in København N, founded in 2014. The company has been dissolved on 18 January 2018. The company was registered under the industry Uoplyst. In 2016, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -6,817 the year before. Equity in the 2016 report amounted to DKK 14,518.